Age-related medial elastocalcinosis in arteries: Mechanisms, animal models, and physiological consequences

Journal of Applied Physiology

Volumn 105, Issue 5, 2008, Pages 1643-1651

  Atkinson, Jeffrey ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Aging; Artery; Calcium; Wall stiffness

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; COLECALCIFEROL; ELASTIN; MATRIX METALLOPROTEINASE; OSTEOCALCIN; PHOSPHATE;

AGING; ARTERIAL CIRCULATION; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY COMPLIANCE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; DIABETES MELLITUS; ELASTIC FIBER; ELASTOLYSIS; EXPERIMENTAL MODEL; HEART FUNCTION; HEART WORK; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; KIDNEY FAILURE; METABOLIC DISORDER; NONHUMAN; OSSIFICATION; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE PRESSURE; REVIEW; SENILE OSTEOPOROSIS; VITAMIN BLOOD LEVEL; VITAMIN D INTOXICATION;

AGE FACTORS; AGING; ANIMALS; ARTERIES; CALCINOSIS; DISEASE MODELS, ANIMAL; ELASTIC TISSUE; ELASTICITY; HUMANS; SPECIES SPECIFICITY; TUNICA MEDIA; VASCULAR DISEASES;

EID: 57049134143     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90476.2008     Document Type: Review

References (131)

1. Abedin M, Tintut Y, Demer LL. Vascular calcification; mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161-1170, 2004.
2. 3 plus nicotine diminishes arterial distensibility in rats. Am J Physiol Heart Circ Physiol 266: H540-H547, 1994.
3. Bailey M, Xiao H, Ogle M, Vyavahare N. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification. Am J Pathol 159: 1981-1986, 2001.
4. Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol 13: 146-155, 2004.
5. Basalyga DM, Simionescu DT, Xiong W, Baxer BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 110: 3480-3487, 2004.
6. Bertelsen S. Hexosamine, hydroxyproline, and calcium levels in the intima of the human aorta as related to age and atherosclerotic changes. J Gerontol 17: 24-26, 1962.
7. Blankenhorn DH. The relation of age and sex to diffuse aortic calcification in man. J Gerontol 19: 72-77, 1964.
8. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemo-dialysis patients: a national study. Am J Kidney Dis 31: 607-617, 1998.
9. Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, ageing and disease. Am J Pathol 20: 665-679, 1944.
10. Bobryshev YV, Lord RSA. Detection of vascular dendritic cells and extracellular calcium-binding protein S-100 in foci of calcification in human arteries. Acta Histochem 28: 371-380, 1995.
11. Bobryshev YV, Lord RSA. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res 29: 689-696, 1995.
12. Boskey AL. Matrix proteins and mineralization: an overview. Connect Tissue Res 35: 357-363, 1996.
13. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809, 1993.
14. Boutinet S, Giummelly P, Capdeville-Atkinson C, Atkinson J. Role of calcium in the alterations of the damping capacity in a rat model of elastocalcinosis (Abstract). Br J Pharmacol 116: 276P, 1995.
15. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin- deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268, 1998.
16. Byrom FD, Dodson LF. The causation of acute arterial necrosis in hypertensive disease. J Pathol Bacteriol 60: 357-368, 1948.
17. Cantini C, Kieffer P, Corman B, Liminana P, Atkinson J, Lartaud-Idjouadiene I. Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension 38: 943-948, 2001.
18. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 20: 1140-1147, 2005.
19. Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 96: 930-938, 2005.
20. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoproteherin. Circ Res 95: 1046-1057, 2004.
21. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 66: 307-317, 2005.
22. Demer LL. A skeleton in the atherosclerosis closet. Circulation 92: 2029-2032, 1995.
23. Doherty TM, Detrano RC. Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54: 224-230, 1994.
24. 3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 96: 1477-1481, 1997.
25. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth TB. Molecular, endocrine and genetic mechanisms of arterial calcification. Endocr Rev 25: 629-672, 2004.
26. Edmonds ME. Medial arterial calcification and diabetes mellitus. Z Kardiol 89: 101-104, 2000.
27. Eisenstein R, Zeruolis L. Vitamin D-induced aortic calcification. Arch Pathol 77: 27-35, 1964.
28. Elias-Smale SE, Kardys I, Ondkerk M, Hofman A, Witteman JCM. C-reactive protein is related to extent and progression of coronary and extracoronary atherosclerosis: results from the Rotterdam study. Atherosclerosis 195: 195-202, 2007.
29. Elliot RJ, McGrath LT. Calcification of the human thoracic aorta during aging. Calcif Tissue Int 54: 268-273, 1994.
30. Essalihi R, Dao HH, Yamaguchi N, Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K treatment. Am J Hypertens 16: 103-110, 2003.
31. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 94: 1597-1604, 1994.
32. Fleckenstein A, Frey M, Zorn J, Fleckenstein G. Calcium, a neglected key factor in hypertension and arteriosclerosis. In: Hypertension: Pathophysiology, Diagnosis and Management, edited by Laragh JH, Brenner BM. New York: Raven, 1990, p. 471-509.
33. Fleisch H, Russell RG, Bisaz S, Muhlbauer R, Williams DA. The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1: 12-18, 1970.
34. Gertz SD, Kurgan A, Eisenberg D. Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo. J Clin Invest 81: 649-656, 1998.
35. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92: 1686-1696, 1993.
36. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralisation. Matrix Biol 19: 622-672, 2000.
37. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 96: 717-722, 2005.
38. Gijsbers BL, van Haarlem LJ, Soute BA, Ebberink RH, Vermeer C. Characterization of a Gla-containing protein from calcified human atherosclerotic plaques. Arteriosclerosis 10: 991-995, 1990.
39. Ginsberg BL, van Haarlem LJM, Soute BAM, Ebberink RHM, Vermeer C. Characterization of a Gla-containing protein from calcified human artherosclerotic plaques. Arteriosclerosis 10: 991-995, 1990.
40. Giummelly P, Colas T, Atkinson J, Robert A, Daly C, Luo D, McGrath JC. Fluorescence of the medial aortic elastic lamella in elastocalcinotic rats (Abstract). Naunyn Schmiedebergs Arch Pharmacol 358: R218, 1998.
41. Greenwald SE. Ageing of the conduit arteries. J Pathol 211: 157-172, 2007.
42. Hall DA. The ageing of connective tissue. Symp Soc Exp Biol 21: 101-125, 1967.
43. Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM 98: 467-484, 2005.
44. Hass GM, Trueheart RE, Taylor CB, Stumpe M. An experimental histologic study of hypervitaminosis D. Am J Pathol 34: 395-431, 1958.
45. Henrion D, Chillon JM, Capdeville-Atkinson C, Vinceneux-Feugier M, Atkinson J. Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload. Br J Pharmacol 104: 966-972, 1991.
46. 3 and nicotine in rats. J Pharmacol Exp Ther 260: 1-8, 1992.
47. Hofbauer LC, Schoppet M. Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358: 257-259, 2001.
48. Hornbeck W, Partridge SM. Conformational changes in fibrous elastin due to calcium ions. Eur J Biochem 51: 73-78, 1975.
49. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 97: 105-114, 2005.
50. Hujairi NM, Afzali B, Goldsmith DJ. Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 43: 234-243, 2004.
51. Ikonomidis JS, Gibson WC, Gardner J, Sweterlitsch S, Thompson RP, Mukherjee R, Spinale FG. A murine model of thoracic aortic aneurysms. J Surg Res 115: 157-163, 2003.
52. Isenberg JC, Simionescu DT, Starcher BC, Vyavahare NR. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 115: 1729-1737, 2007.
53. Janzen J, Vuong PN. Arterial calcifications: morphological aspects and their pathological implications. Z Kardiol 90: 6-11, 2001.
54. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Endovasc Surg 30: 476-488, 2005.
55. Jegger D, de Silva R, Jeanrenaud X, Nasratullah M, Tevaearai H, van Segesser LK, Segers P, Gaillard V, Atkinson J, Lartaud I, Stergiopulo N. Ventricular-arterial coupling in a rat model of reduced arterial compliance provoked by hypervitaminosis D and nicotine. Am J Physiol Heart Circ Physiol 291: H1942-H1951, 2006.
56. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification. Pathobiological mechanisms and clinical implications. Circ Res 99: 1044-1059, 2006.
57. Kanabrocki EL, Gordon Fels I, Kaplan E. Calcium, cholesterol, and collagen levels in human aortas. J Gerontol 15: 383-387, 1960.
58. Katsuda S, Okada Y, Minamoto T, Oda Y, Matsui Y, Nakanishi I. Collagens in human atherosclerosis. Arterioscler Thromb 12: 494-502, 1992.
59. Keeley FW, Partridge SM. Amino acid composition and calcification of human aortic elastin. Atherosclerosis 19: 287-296, 1974.
60. Kieffer P, Robert A, Capdeville-Atkinson C, Atkinson J, Lartaud-Idjouadiene I. Age-related arterial calcification in rats. Life Sci 66: 2371-2381, 2000.
61. Kitauchi T, Yoshida K, Yoneda T, Saka T, Yoshikawa M, Ozono S, Hirao Y. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis. Clin Exp Nephrol 8: 48-53, 2004.
62. Kramsch DM, Aspen AJ, Aspen CS. Suppression of experimental atherosclerosis by the Ca antagonist lanthanum. J Clin Invest 65: 967-981, 1980.
63. Kramsch DM, Aspen AJ, Rozler LJ. Atherosclerosis: prevention by agents not affecting abnormal levels of blood lipids. Science 213: 1511-1512, 1981.
64. Lansing AI, Ales M, Rosenthal TB. Calcium and elastin in human arteriosclerosis. J Gerontol 5: 12-119, 1949.
65. Lartaud-Idjouadiène I, Lompré AM, Kieffer P, Colas T, Atkinson J. Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. Hypertension 34: 63-69, 1999.
66. Lehto S, Nuskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. Arterioscler Thromb Vasc Biol 16: 978-983, 1996.
67. Litauchi T, Yoshida K, Yoneda T, Saka T, Yoshikawa M, Ozano S, Hirao Y. Association between pentoside and arteriosclerosis in patients receiving hemodialysis. Clin Exp Nephrol 8: 48-53, 2004.
68. London GM, Marchais Safar SJ, ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM. Aortic and large artery compliance in end-stage renal failure. Kidney Int 37: 137-142, 1990.
69. London GM, Guerin AP, Marchais SJ, Metiver F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003.
70. Longo GM, Xiong W, Greiner C, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110: 625-632, 2002.
71. Maarek BC, Simon AC, Levenson J, Pithois-Merli I, Bouthier JD. Heterogeneity of the atherosclerotic process in systemic hypertension poorly controlled by drug treatment. Am J Cardiol 2: 1111-1120, 1987.
72. Marchais SJ, Boussac I, Guerin AP, Delavaux G, Metivier F, London GM. Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. J Cardiovasc Pharmacol 18, Suppl: S14-S18, 1991.
73. Marque V, Kieffer P, Gayraud B, Lartaud-Idjouadiène I, Ramirez F, Atkinson J. Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome. Atheroscler Thromb Vasc Biol 21: 1184-1189, 2001.
74. Marque V, van Essen H, Struijker-Boudier H, Atknson J, Lartaud-Idjouadiène I. Determination of aortic modulus by pulse wave velocity and wall tracking in a rat model of aortic stiffness. J Vasc Res 38: 546-550, 2001.
75. McCullagh KG. Arteriosclerosis in the African elephant. Atherosclerosis 21: 37-59, 1975.
76. Megnien JL, Simon A, Lemariey M, Plainfossé MC, Levenson J. Hypertension promotes coronary calcium deposit in asymptomatic men. Hypertension 27: 949-954, 1996.
77. Méndez J, Tejada C. Chemical composition of aortas from Guatemalans and North Americans. Am J Clin Pathol 51: 598-602, 1969.
78. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B, Levy B. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol Regul Integr Comp Physiol 267: R124-R135, 1994.
79. Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin reverses osteoporosis by inhibiting endosteal oseoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192: 463-474, 2000.
80. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31: 509-519, 2001.
81. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapmann SB, Fineberg N, Kopecky K. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61: 638-647, 2002.
82. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95: 560-567, 2004.
83. Moe SM, Chen NX. Inflammation and vascular calcification. Blood Purif 23: 64-71, 2005.
84. Moe SM. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest 36: 51-62, 2006.
85. Molinari-Tossati MP, Gotte L, Moret V. Some features of the binding of calcium to elastin. Calcif Tissue Int 6: 329-334, 1971.
86. Mönckeberg JG. Uber die reine Mediaverkalkung der Extremitatenarterien und ihr Verhalten zür Arteriosklerose. Virchows Arch 171: 141-167, 1903.
87. Morgan AJ, Bellmay D. Influence of age and sex on the calcification of rat aorta in relation to bone mineralization. Age Ageing 4: 73-85, 1975.
88. Nakao J, Orimo H, Ooyama T, Shiraki M. Low serum estradiol levels in subjects with arterial calcification. Atherosclerosis 34: 469-474, 1979.
89. 3 plus nicotine. J Vasc Res 34: 386-398, 1997.
90. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J. Calcification of medial elastic fibres and aortic elasticity. Hypertension 29: 999-1006, 1997.
91. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehis O, Schaefer F. Advance coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106: 100-105, 2002.
92. Orimo H, Tershita K, Nakamura T, Ohshima J. Ca and atherosclerosis. J Nutr Sci Vitaminol 31, Suppl: S33-S36, 1985.
93. O'Rourke MF. Pulsatile arterial hemodynamics in hypertension. Aust N Z J Med 6: 40-48, 1976.
94. Parhami F, Demer LL. Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids? Curr Opin Lipidol 8: 312-314, 1997.
95. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation of the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680-687, 1997.
96. Potokar M, Schmidt-Dunker M. The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo. Atherosclerosis 30: 313-320, 1978.
97. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits arterial calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21: 1610-1616, 2001.
98. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18: 379-388, 1998.
99. Proudfoot D, Skepper JN, Hegyi L, Farzaneh-Far A, Shanahan CM, Weissberg PL. The role of apoptosis in the initiation of vascular calcification. Z Kardiol 90: 43-46, 2001.
100. Reaven PD, Sacks J. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia 48: 379-385, 2005.
101. Robert A, Tran NNP, Giummelly P, Atkinson J, Capdeville-Atkinson C. Sensitivity of norepinephrine-evoked vasoconstriction to pertussis toxin in the old rat. Am J Physiol Regul Integr Comp Physiol 274: R1604-R1612, 1998.
102. Rosenblum IY, Flora L, Eisenstein R. The effect of disodium ethane-1-hydroxy-1,1-disphosphonate (EHDP) on a rabbit model of atheroarteriosclerosis. Atherosclerosis 22: 411-424, 1975.
103. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. Transforming growth factor-beta-dependent events in vascular remodelling following arterial injury. J Vasc Res 40: 37-46, 2003.
104. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-2309, 2007.
105. Schechter AD, Spirn B, Rossikhinia M, Giesen PLA, Bogdanov V, Fallon JT, Fisher EA, Schnapp LM, Nemerson Y, Taubman MB. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 87: 126-132, 2000.
106. Schinke T, Karsenty G. Vascular calcification-a passive process in need of inhibitors. Nephrol Dial Transplant 15: 1272-1274, 2000.
107. Schurgers LJ, Teunissen KJF, Knapen MHJ, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JPM, Vermeer C. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein. Arterioscler Thromb Vasc Biol 25: 1629-1633, 2005.
108. Shanahan CM, Cary NRB, Salisbury JR, Proudfoot D, Weinberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins is association with Mönckeberg's sclerosis. Evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176, 1999.
109. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification-lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26: 1423-1430, 2006.
110. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial 20: 103-109, 2007.
111. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-β1 induce osteogenic reponses in smooth muscle cells. Biochem Biophys Res Commun 334: 524-532, 2005.
112. Simionescu A, Simionescu DT, Vyavahare NR. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-β1. Am J Pathol 171: 116-123, 2007.
113. Simon A, Levenson J. Early detection of subclinical atherosclerosis in asymptomatic subjects at high risk for cardiovascular disease. Clin Exp Hypertens 15: 1069-1076, 1993.
114. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebershold R, Schinke T, Karsenty G, Giachelli CM. Smooth muscle cell phenotypic transition associated with calcification-upregulation of Cbfa1 and down regulation of smooth muscle lineage markers. Circ Res 89: 1147-1154, 2001.
115. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 1: 178-185, 2003.
116. Tanimura A, McGregor DH, Anderson HC. Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 172: 173-177, 1983.
117. Tatchum-Talom R, Niederhoffer N, Amin F, Makki T, Tankosic P, Atkinson J. Aortic stiffness and left ventricular mass in a rat model of isolated systolic hypertension. Hypertension 26: 963-970, 1995.
118. Toussaint ND, Lau KK, Polkinghorne KR, Kerr PG. Measurement of vascular calcification using CT fistulograms. Nephrol Dial Transplant 22: 484-490, 2007.
119. Towler DA. Calciotropic hormones and arterial physiology: "D"-lightful insights. J Am Soc Nephrol 18: 369-373, 2007.
120. Tran NNP, Spitzbarth E, Robert A, Giummelly P, Atkinson J, Capdeville-Atkinson C. Nitric oxide lowers the calcium sensitivity of tension in the rat tail artery. J Physiol 507: 163-174, 1998.
121. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286: E686-E696, 2004.
122. Vervoort LMT, Ronden JE, Thijssen HHW. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation. Biochem Pharmacol 54: 871-876, 1997.
123. Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI-Atheromatous affection of arteries 1858. Nutr Rev 47: 23-25, 1989.
124. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760, 1997.
125. Waugh D, Maximchuk AJ, Stuart JR. Age changes in composition of aorta of the rabbit. Proc Soc Exp Biol Med 93: 197-200, 1956.
126. Wilens SL. The post mortem elasticity of the adult aorta. Its relation to age and to distribution of intimal atheromas. Am J Pathol 13: 811-834, 1937.
127. Winlove CP, Parker KH, Avery NC, Bailey AJ. Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties. Exp Gerontol 39: 249-254, 2004.
128. Yamauchi-Takihara K, Azuma J, Kishimoto S. Taurine protects against experimental calcinosis in mice. Biochem Biophys Res Commun 140: 679-683, 1986.
129. Yu SY, Blumenthal HT. The calcification of elastic fibres. I. Biochemical studies. J Gerontol 18: 119-126, 1963.
130. Yu SY, Blumenthal HT. The calcification of elastic fibres. II. Ultramicroscopic characteristics. J Gerontol 18: 127-134, 1963.
131. Yu SY, Blumenthal HT. The calcification of elastic fibres. IV. Epinephrine and beta-aminoproprionitrile-induced calcification in animal aortas. J Atheroscler Res 5: 159-173, 1965.